>
Switch to:

Indaptus Therapeutics Debt-to-Equity

: 0.05 (As of Jun. 2021)
View and export this data going back to 2021. Start your Free Trial

Indaptus Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was $0.63 Mil. Indaptus Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2021 was $0.00 Mil. Indaptus Therapeutics's Total Stockholders Equity for the quarter that ended in Jun. 2021 was $13.94 Mil. Indaptus Therapeutics's debt to equity for the quarter that ended in Jun. 2021 was 0.05.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Indaptus Therapeutics's Debt-to-Equity or its related term are showing as below:

NAS:INDP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05   Med: 0.05   Max: 0.05
Current: 0.05

During the past 0 years, the highest Debt-to-Equity Ratio of Indaptus Therapeutics was 0.05. The lowest was 0.05. And the median was 0.05.

NAS:INDP's Debt-to-Equity is ranked lower than
99.99% of the 207 Companies
in the Biotechnology industry.

( Industry Median: 0.11 vs. NAS:INDP: 0.05 )

Indaptus Therapeutics Debt-to-Equity Historical Data

The historical data trend for Indaptus Therapeutics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indaptus Therapeutics Annual Data
Trend
Debt-to-Equity

Indaptus Therapeutics Quarterly Data
Jun20 Mar21 Jun21
Debt-to-Equity N/A - 0.05

Competitive Comparison

For the Biotechnology subindustry, Indaptus Therapeutics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Indaptus Therapeutics Debt-to-Equity Distribution

For the Biotechnology industry and Healthcare sector, Indaptus Therapeutics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Indaptus Therapeutics's Debt-to-Equity falls into.



Indaptus Therapeutics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Indaptus Therapeutics's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Indaptus Therapeutics's Debt to Equity Ratio for the quarter that ended in Jun. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indaptus Therapeutics  (NAS:INDP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Indaptus Therapeutics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Indaptus Therapeutics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Indaptus Therapeutics Business Description

Indaptus Therapeutics logo
Industry
Healthcare » Biotechnology NAICS : 541714 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)